View Older Stories View More Recent Stories

Feb 5, 2024 08:00AM Boston Scientific to Participate in TD Cowen's 44th Annual Health Care Conference
Jan 31, 2024 06:30AM Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
Jan 31, 2024 06:25AM Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System
Jan 8, 2024 07:00AM Boston Scientific Announces Agreement to Acquire Axonics, Inc.
Jan 5, 2024 08:00AM Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
Dec 28, 2023 04:00PM Boston Scientific (BSX) Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System
Dec 28, 2023 04:00PM Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation
Nov 17, 2023 09:01AM Boston Scientific (BSX) Closes Acquisition of Relievant Medsystems
Nov 17, 2023 09:00AM Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.
Nov 1, 2023 08:00AM Boston Scientific to Participate in Stifel's 2023 Healthcare Conference
Oct 26, 2023 06:30AM BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023
Oct 25, 2023 02:29PM Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial
Oct 24, 2023 03:18PM REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS™ Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary Embolism
Oct 2, 2023 06:30AM Boston Scientific Announces Conference Call Discussing Third Quarter 2023 Results
Sep 19, 2023 07:01AM Boston Scientific (BSX) to Acquire Relievant Medsystems for Over $850 Million
Sep 19, 2023 07:00AM Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Sep 6, 2023 04:01PM Boston Scientific (BSX) Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device
Sep 6, 2023 04:00PM Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device
Sep 5, 2023 08:30AM Boston Scientific Announces 2023 Investor Day Meeting and Conference Call Discussing Third Quarter 2023 Results
Aug 28, 2023 05:10AM Boston Scientific (BSX) Reports ADVENT Study of the FARAPULSE Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints
Aug 27, 2023 06:13AM ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints
Aug 8, 2023 04:01PM Boston Scientific Receives FDA Approval for the POLARx™ Cryoablation System
Jul 27, 2023 06:34AM BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR SECOND QUARTER 2023
Jun 28, 2023 09:00AM Boston Scientific Announces Conference Call Discussing Second Quarter 2023 Results
Jun 27, 2023 06:31AM Boston Scientific (BSX) Appoints Jessica L. Mega and Susan E. Morano to its Board
Jun 27, 2023 06:30AM Boston Scientific Elects Dr. Jessica L. Mega and Susan E. Morano to Board of Directors
May 30, 2023 04:30PM Boston Scientific Announces Conversion Date of Series A Mandatory Convertible Preferred Stock
May 20, 2023 02:54PM Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies
May 15, 2023 09:00AM Boston Scientific to Participate in Bernstein's 39th Annual Strategic Decisions Conference
Apr 26, 2023 06:30AM Boston Scientific Announces Results for First Quarter 2023
Apr 21, 2023 08:30AM Boston Scientific Reports New Progress With Action for a Healthier, More Equitable World
Apr 3, 2023 09:30AM Boston Scientific Announces Conference Call Discussing First Quarter 2023 Results
Feb 13, 2023 09:30AM Boston Scientific to Participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference
Feb 3, 2023 06:45AM Boston Scientific (BSX) Receives FDA Clearance for LithoVue
Feb 3, 2023 06:45AM Boston Scientific Receives FDA Clearance for LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System
Feb 1, 2023 06:30AM BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2022
Jan 3, 2023 09:30AM Boston Scientific to Participate in J.P. Morgan Healthcare Conference and Announces Conference Call Discussing Fourth Quarter 2022 Results
Dec 12, 2022 06:48AM Boston Scientific (BSX) to acquire majority stake in Acotec Scientific
Dec 11, 2022 05:17PM Boston Scientific Announces Strategic Investment to Acquire Majority Stake of Acotec Scientific Holdings Limited
Nov 29, 2022 07:01AM Boston Scientific (BSX) to Acquire Apollo Endosurgery (APEN) for $10 Per Share, $615 million Deal
Nov 29, 2022 07:00AM Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
Nov 27, 2022 12:05PM Late-Breaking Post-Market Study Data Reinforce Clinical Procedural Success and Safety of the ACURATE neo2™ Aortic Valve System
Nov 1, 2022 09:30AM Boston Scientific Announces Upcoming Conference Schedule
Oct 26, 2022 06:30AM Boston Scientific Announces Results for Third Quarter 2022
Oct 3, 2022 09:30AM Boston Scientific Announces Conference Call Discussing Third Quarter 2022 Results
Sep 17, 2022 11:21AM Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL™ Cerebral Protection System
Sep 15, 2022 04:30PM Nordson Corporation Appoints Milton Morris to Board of Directors
Sep 6, 2022 06:57AM Boston Scientific (BSX) Granted FDA Approval for Expanded Labeling of WATCHMAN FLX LAAC
Sep 6, 2022 06:55AM Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX™ LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option
Aug 16, 2022 02:00PM Boston Scientific Announces Upcoming Conference Schedule
View More Recent Stories View Older Stories